title: Locally advanced versus metastatic pancreatic cancer: two different diseases with two different treatment approaches?
abstract: The results of the SCALOP trial were reviewed and interpreted at the light of previous trials and of the more recent LAP-07 trial. In this latter trial the role of radiotherapy after an induction chmeotherapy has been questioned. Based on these findings data from the SCALOP trial loose most of their value. In fact, while it showed that capecitabine may be combined with radiotherapy more safely than gemcitabine and it could be a standard regimen as a consolidation regimen after an induction chemotherapy, the LAP-07 trial showed that radiotherapy in combination with chemotherapy does not add any valuable effect to chemotherapy alone.
authors.affiliation: Department of Medical Oncology and Center for Cancer Genetics, Università Politecnica delle Marche, Ancona, Italy. cascinu@yahoo.com.
authors.forename: Stefano
authors.initials: S
authors.lastname: Cascinu
keywords: Pancreatic cancer; chemoradiotehrapy; locally advanced disease